Brainstorm Cell Therapeut...

NASDAQ: BCLI · Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 21, 2025, 3:40 PM
0.64
0.00%
After-hours: Aug 21, 2025, 03:40 PM EDT

Brainstorm Cell Therapeutics Revenue

Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending June 30, 2025, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
849K
Revenue Growth
n/a
Price / Sales Ratio
14.2
Revenue / Employee
31.44K
Employees
27
Market Cap
6.3M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 849K +Infinity%
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 +-100.00%
Dec 31, 2019 -366K -Infinity%
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Mar 31, 2005 0 n/a
Mar 31, 2004 0 -100.00%
Mar 31, 2003 82.89K +261.96%
Mar 31, 2002 22.9K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.